| Revenue growth | 25% YoY growth to INR 1,300 Cr in Q1 FY27. |
|---|---|
| Margins | EBITDA margins improved; Specialty Chemicals at 26%, Nutrition at 15%. |
| Order book | CDMO funnel of 100+ molecules with INR 3,500+ Cr peak potential. |
| Demand visibility | Resilient demand across chemical industry; strong traction in electronic semicon segment. |
| Management confidence | High; confident in Pinnacle strategy and sequential improvement in coming quarters. |
Growth
Revenue grew 25% YoY to INR 1,300 Cr; EBITDA rose 36% YoY to INR 209 Cr; PAT increased 41% YoY to INR 106 Cr.
Outlook
Maintained FY27 EBITDA guidance of INR 750-800 Cr. New multipurpose plant commissioning by end of calendar year 2026.
Risks
Geopolitical uncertainties in the Middle East; pricing pressure in commoditized pyridine; volatility in acetyl segment and raw material costs.
Last quarter's promises, checked
Delivered
- Sequential revenue/EBITDA growth in Q1 FY27 → Delivered (Q1 Rev 1,300 Cr vs Q4 1,179 Cr; EBITDA 209 Cr vs 172 Cr) (= BEAT)
- Specialty margin 23-25% → Delivered 26% (= BEAT)
- Nutrition margin ~14% → Delivered 15% (= BEAT)
Partly delivered
- FY27 EBITDA growth target 20% (min ~INR 612 Cr) → Guidance maintained at 750-800 Cr (= ON TRACK)
Investor Presentation filed with BSE, NSE: JUBLINGREA. Summary written with AI assistance from the document.
Jubilant Ingrevia Ltd: key numbers
- Share price
- ₹656.10
- Market cap
- ₹10,450 Cr
- Revenue (annual)
- ₹4,388 Cr
- Net profit (annual)
- ₹277.9 Cr
- P/E (TTM)
- 33.9×Sector 37.5×
- Promoter holding
- 45.22%+0.00% QoQ
- FII holding
- 6.49%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jubilant Ingrevia Ltd
All →Jubilant Ingrevia Debt & Borrowing: ₹100 Cr
Jubilant Ingrevia has issued Commercial Papers worth Rs. 100 Crore. This issuance, with a 90-day tenure, falls within the previously approved Rs. 600 Crore outstanding limit.
- Value
- ₹100.0 Cr
Jubilant Ingrevia Employee Stock Options
Jubilant Ingrevia Employees Welfare Trust sold 8,807 shares worth Rs.0.56 Crore. The sale was executed to facilitate the exercise of ESOP options.
- Value
- ₹0.56 Cr
Jubilant Ingrevia Capital Structure Change
Jubilant Ingrevia Employees Welfare Trust sold 2,587 equity shares worth Rs. 0.17 Crore on September 11, 2026.
- Value
- ₹0.17 Cr
Jubilant Ingrevia Employee Stock Options
Jubilant Ingrevia Employees Welfare Trust sold 5,622 equity shares for Rs. 0.38 Crore. The transfer was executed pursuant to the exercise of ESOPs.
- Value
- ₹0.38 Cr
Jubilant Ingrevia Q1 FY27 Results: Net Profit ₹106 Cr, Up 41.3% YoY
Jubilant Ingrevia Ltd reported revenue from operations of ₹1,300 Cr (+25.2% YoY) and net profit of ₹106 Cr (+41.3% YoY) for Q1 FY27.
- Key figure
- Net profit ₹106 Cr · +41.3% YoY
Jubilant Ingrevia Q1 FY27 Results: Net Profit ₹105.8 Cr, Up 40.9% YoY
Jubilant Ingrevia Ltd reported revenue from operations of ₹1,300 Cr (+25.3% YoY) and net profit of ₹105.8 Cr (+40.9% YoY) for Q1 FY27.
- Key figure
- Net profit ₹105.8 Cr · +40.9% YoY